JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways
Stem Cell
Wnt/β-catenin

Wnt/β-catenin

A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A1877 XAV-939
1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A8396 CHIR-99021 (CT99021) HCl

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL
A8601 Tankyrase Inhibitors (TNKS) 49

Target: Tankyrases

Summary: Tankyrase inhibitor

≥22.45 mg/mL
A8685 Wnt-C59
2 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
B2307 LGK-974
1 Citation

Summary: PORCN inhibitor,potent and specific

insoluble in H2O; ≥19.8 mg/mL
B5614 Cardionogen 1

Summary: Wnt signaling modulator

<5.49 mg/mL
B5979 CCT251545

Summary: Orally bioavailable and potent WNT signaling inhibitor

≥42.2 mg/mL
B2306 IWR-1-endo
1 Citation

Summary: Potent Wnt signaling inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.45 mg/mL